MetaADEDB 2.0 @ LMMD
flibanserin
(PPRRDFIXUUSXRA-UHFFFAOYSA-N)
Structure
SMILES
O=c1[nH]c2c(n1CCN1CCN(CC1)c1cccc(c1)C(F)(F)F)cccc2
Type(s)
Approved; Investigational
ATC code(s)
G02CX02
Molecular Formula:
C20H21F3N4O
Molecular Weight:
390.402
Log P:
3.1735
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
1
TPSA:
44.27
CAS Number(s):
167933-07-5
Synonym(s)
1.
flibanserin
2.
1-(2-(4-(3-trifluoromethylphenyl)piperazin-1-yl)ethyl)benzimidazol(1H)-2-one
3.
Addyi
4.
BIMT 17
5.
BIMT-17
External Link(s)
MeSHC098107
PubChem Compound6918248
ChEBI90865
CHEMBLCHEMBL231068
DrugBankDB04908
DrugCentral5022
IUPHAR/BPS Guide to PHARMACOLOGY8182
KEGGdr:D02577
Therapeutic Target DatabaseD0S9CB
ZINC52716421
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Therapeutic response unexpectedFAERS: 13US FAERS
2DizzinessFAERS: 12US FAERS
3Drug ineffectiveFAERS: 12US FAERS
4Product use issueFAERS: 7US FAERS
5SomnolenceFAERS: 7US FAERS
6FatigueFAERS: 5US FAERS
7Drug dose omissionFAERS: 4US FAERS
8HypotensionFAERS: 4US FAERS
9NauseaFAERS: 4US FAERS
10Weight decreasedFAERS: 4US FAERS
11Accidental exposure to product by childFAERS: 3US FAERS
12AstheniaFAERS: 3US FAERS
13Accidental overdoseFAERS: 2US FAERS
14Burning sensationFAERS: 2US FAERS
15Depressed Level of ConsciousnessFAERS: 2US FAERS
16Depressed moodFAERS: 2US FAERS
17Drug effect incompleteFAERS: 2US FAERS
18Feeling abnormalFAERS: 2US FAERS
19HeadacheFAERS: 2US FAERS
20MalaiseFAERS: 2US FAERS
21Abdominal discomfortFAERS: 1US FAERS
22AngerFAERS: 1US FAERS
23AnxietyFAERS: 1US FAERS
24AtaxiaFAERS: 1US FAERS
25ColitisFAERS: 1US FAERS
26ConstipationFAERS: 1US FAERS
27DiverticulumFAERS: 1US FAERS
28Drug administration errorFAERS: 1US FAERS
29Drug dispensing errorFAERS: 1US FAERS
30Drug ineffective for unapproved indicationFAERS: 1US FAERS
31Drug prescribing errorFAERS: 1US FAERS
32Expired product administeredFAERS: 1US FAERS
33Feeling ColdFAERS: 1US FAERS
34Female Orgasmic DisorderFAERS: 1US FAERS
35Impaired driving abilityFAERS: 1US FAERS
36Inappropriate schedule of drug administrationFAERS: 1US FAERS
37Incorrect dose administeredFAERS: 1US FAERS
38LethargyFAERS: 1US FAERS
39Medication ErrorFAERS: 1US FAERS
40Mental impairmentFAERS: 1US FAERS
41Mood swingsFAERS: 1US FAERS
42Muscle FatigueFAERS: 1US FAERS
43MyalgiaFAERS: 1US FAERS
44MyoclonusFAERS: 1US FAERS
45Negative thoughtsFAERS: 1US FAERS
46NervousnessFAERS: 1US FAERS
47No adverse eventFAERS: 1US FAERS
48PainFAERS: 1US FAERS
49SluggishnessFAERS: 1US FAERS
50SwellingFAERS: 1US FAERS
51SyncopeFAERS: 1US FAERS
52Therapeutic response delayedFAERS: 1US FAERS
53Toxicity to various agentsFAERS: 1US FAERS
54TremorFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.